Influence of treatment schedules and route of administration on the chemotherapy of murine leukemia L1210 with 5(or 4)-[3,3-bis( 2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196).
D000284:Administration, Oral; D000818:Animals; D007093:Imidazoles / Q000008:administration & dosage* / Q000627:therapeutic use; D007274:Injections, Intraperitoneal; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice; D014227:Triazines / Q000008:administration & dosage* / Q000627:therapeutic use
D007093:Imidazoles; D014227:Triazines